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Nucleosides and their structural variants are a well-established 
and important class of antiviral and anticancer agents.[1]  More 
recently, they have become the chemical centerpiece of the 
development of genetic therapies, biological probes, and modern 
DNA sequencing technologies, as well as investigations into the 
molecular mechanisms of chemical carcinogenesis and DNA 
repair.[2]  Due to this broad utility, the development of more 
efficient methods for the synthesis of nucleoside analogues 
remains a high priority.  Currently the most widely used method 
of ribonucleoside synthesis is the Vorbrüggen modification of 
the silyl-Hilbert-Johnson reaction.[3]  This approach assembles 
the important nucleosidic bond by joining a glycosyl donor with 
a silylated nucleobase, under Lewis acid promotion.[4] A high-
throughput two-step glycosylation/deprotection sequence for the 
synthesis of nucleoside libraries is a notable recent 
improvement.[5],[6]  Nevertheless, despite these advances the 
stoichiometric use of Lewis acids, e.g., trimethylsilyl triflate 
(TMSOTf), remains the state of the art.  The limitations of this 
aspect are not insignificant and include the functional group 
compatibility of the Lewis acid and the quenching, separation, 
and disposal thereof, particularly on preparative scale. 
We now introduce pyridinium triflate salts as efficient 
glycosylation catalysts for the synthesis of nucleosides and 
nucleoside analogues.  We further report the development of a 
general and scalable method for the continuous flow synthesis of 
nucleosides.  An in-line deprotection step allows for one-flow, 
multi-step synthesis of unprotected nucleosides without 
intermediate isolation or purification operations.   
To the best of our knowledge this is the first general method 
of nucleoside formation catalyzed by Brønsted acids, such as 
pyridinium trifaltes.[7]  The high temperatures readily available 
to flow synthesis make this new paradigm possible and practical. 
[8] 
An important goal at the outset of our studies was the 
discovery of a catalytic alternative to traditional Lewis acid 
glycosylation promoters.  Continuous flow techniques and 
microreactor technology are rapidly emerging as complements to 
traditional batch methods of organic synthesis,[9],[10] and we 
reasoned that the attributes of these tools would provide access 
to reaction conditions not generally feasible in batch.  We also 
anticipated that an additional advantage of the use of a sub-
stoichiometric quantity of the promoter would be that subsequent 
transformations could be incorporated into the flow system 
without additional quenching or purification operations.  
A critical metric of any new catalyst for nucleoside synthesis 
would be throughput, i.e., high product yield in a short reaction 
time, in order to facilitate a single-pass continuous flow 
approach.  Our initial results in batch (microwave irradiation) 
indicated that pyridinium triflates would satisfy these 
requirements.  A catalytic amount (5 mol%) of several 
pyridinium triflates effected quantitative conversion and high 
yield in fewer than 5 minutes at 150 °C. As such, the 
commercially available, inexpensive ribofuranose 1 and silyl 
protected thymine 2a could be combined to form the desired β-
anomer of nucleoside 3a (Table 1, entry 3-6). 
We discovered that both the pyridinium cation and triflate 
counterion play essential roles in this process.  Other pyridinium 
salts derived from alternative acids failed to show any 
conversion under these conditions (Table 1, entry 7-10).  
Moreover, triflate salts derived from alkylamines afforded 
inferior results; for example, ethyldiisopropylamine provided 3a 
in only 22% yield (Table 1, entry 11).  For practical reasons the 
easy-to-handle salt of 2,6-di-tert-butyl-4-methylpyridine was 
preferred, but for large-scale preparative experiments (vide 
infra) we would suggest the use of less expensive and 
commercially available pyridinium salts, such as pyridinium 
triflate itself.  
Table 1. Selection of the catalyst.[a] 
 
 Catalyst Yield [%][b] 
1 none 0 
s2 Trimethylsilyl triflate 91 
3 Pyridinium triflate 98 
4 2,6-Lutidinium triflate 96 
5 2,4,6-Collidinium triflate 97 
6 4a (X = triflate) 98 
7 4b (X = methanosulfonate) 0 
8 4c (X = trifluoroacetate) 0 
9 4d (X = chloride) 0 
10 Pyridinium p-toluenesulfonate 0 
11 Ethyldiisopropylamine triflate 22[c] 
[a] Conditions: 0.2 mmol of 1, 0.22 mmol of 2a, 1.5 mL of CH3CN, 5 
mol% of catalyst in 0.5-2 ml MW vial (Biotage Initiator). [b] Isolated 
yield. [c] Recovered 71% of 1. 
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It should be noted that even though TMSOTf gave 
satisfactory yield under microwave conditions (Table 1, entry 2), 
the flow variant was not feasible to run due to decomposition of 
the  ribofuranose and subsequent clogging of the reactor (see 
Supporting Information for details).  Moreover, even with the use 
of 1 equivalent of pyridinium triflate, no conversion was 
observed after 20 h under otherwise identical batch conditions at 
room temperature, indicating that the high temperature provided 
by flow synthesis would be necessary for this new catalyst 
system to be of any practicality.   
A significant challenge of converting the batch conditions into a 
continuous flow process related to the poor solubility of persilylated 
heterocyclic bases in CH3CN and required careful design of the 
reactor setup.[11]  We found it was necessary to heat the bases (2a-i) 
to 40 °C prior to flowing them into the reactor in order to prevent 
their precipitation.  In addition, the T-mixer where both reagent 
streams meet had to be held at 100–150 °C (the reaction 
temperature) in order to prevent solid formation and subsequent 
clogging (see the Supporting Information for details of the reactor 
setup).  
The results of preparative scale batch and continuous flow 
experiments are shown in Table 2.  The reaction tolerates a 
variety of nucleobases including 5-substituted uracils (2a-f), 
cytosine (2g), and the purine bases guanine (2h) and adenine 
(2i).  Notable features of the reaction include low catalyst 
loadings (typically 5 mol%), short reaction times (0.5-20 min), 
and high yields following off-line purification (80-99%, with 6 
out of 9 examples ≥ 95%). 
Differences in the required reaction time for the various 
nucleobases can be attributed to reversible σ-complex formation 
between the silylated bases and the pyridinium catalyst (weak 
Brønsted acid).[12]  This trend is clearly seen in the series of 
substituted uracils 2a-c where reaction time and temperature can 
be correlated to the basicity of the pyrimidines (2a>2b>2c).  In 
the case of uracils with small substituents in the 5 position 
(Table 2, entry 4 and 6) and cytosine (Table 2, entry 7), N1, N3-
bisnucleoside by-products were observed in both batch and flow 
experiments.  It was also found that the tubing diameter had 
significant impact on the formation of bisalkylation by-product. 
Interestingly, we observed that when tubing with a larger 
inner diameter (0.75 mm) was used, the amount of bisalkylation 
by-product increased (and correspondingly the yield of the 
desired product decreased) when compared to the related batch 
experiment.  These anomalous results could be overcome by 
simply employing a reactor with a smaller inner diameter (0.5 
mm) which promotes a more uniform laminar flow profile and 
hence increased accuracy of the residence times (see Supporting 
Information for details).[13]  In the case of cytosine, guanine, and 
adenine (2g-i), residual bis(trimethylsilyl)acetamide (BSA) from 
the silylation step had no negative influence in the glycosylation 
reaction. 
To demonstrate the scalability of the reaction we directly 
transferred the optimized conditions to the commercially 
available flow system from Vapourtec (Scheme 1).[14]  This 
reactor comprises two independent HPLC pumps that deliver 
substrate solutions from reservoirs into the reactor.  Mixing 
occurs in a T-joint connector and the resulting solution is then 
pumped into a 2 mL PFA tubing (1 mm i.d.) reactor that is 
heated in a convection chamber.  By maintaining all the key 
parameters from the small-scale flow reactor (concentration, 
catalyst loading, residence time, and temperature), we obtained 
26 g of 3b (7.4 g/h) in 3.5 h, without any further optimization.  
The isolated yield for the reaction of 3b (99%) was consistent 
with that attained using the microscale flow reactor.   
Table 2. Synthesis of nucleosides in batch and continuous flow. 
 
 Base Method[a] 4a (mol%) 
Temp 
[°C] 
Time[b] 
[min] 
Yield[c] 
[%] 
1 2a MW 5 150 3 99 
  Flow 5 150 5 96 
2 2b MW 5 120 1 99 
  Flow 5 120 1 99 
3 2c MW 5 120 0.5 96 
  Flow[d] 5 120 0.5 99 
4 2d MW 10 100 10 85 (10, 3) 
  Flow[d] 10 100 10 87 (9, 0) 
5 2e MW 5 120 1 99 
  Flow 5 120 3 99 
6 2f MW 5 120 5 85 (12, 3) 
  Flow[d] 10 100 20 88 (11, 0) 
7 2g MW 5 150 10 83 (11, 0) 
  Flow[d] 15 120 5 80 (6, 14) 
8 2h MW 5 150 5 95[e] 
  Flow 5 150 5 95[f] 
9 2i MW 5 150 3 99 
  Flow 5 150 5 95 
[a] MW method:  0.2 mmol of 1, 0.22 mmol of 2a, 1.5 mL of CH3CN, 
catalyst in 0.5-2 ml MW vial (Biotage Initiator).  Flow method:  Flow 
reactions were run in 100 µL PFA, 0.75 mm i.d. tubing reactor unless 
specified otherwise. [b] Time of MW reaction refers to hold time 
(temperature ramp time ca. 1 min and cooling time ca. 45 sec); time 
of flow reaction refers to residence time in the PFA tubing reactor. [c] 
Isolated yield, numbers in parenthesis refer to N1, N3-bisnucleoside 
by-product and recovered ribofuranose, respectively. [d] 100 µL PFA, 
0.5 mm i.d. tubing reactor. [e] Mixture of isomers N9:N7 4.5:1. [f] 
Mixture of isomers N9:N7 4.7:1. 
 
Scheme 1. Large scale synthesis of 3b using the Vapourtec R2+/R4 
flow system. 
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Under similar conditions, reaction with pyridinium triflate (5 
mol%) as a catalyst afforded 3b in 96% yield. 
Finally, we turned our attention to the development of a one-
flow, multi-step synthesis of fully deprotected nucleosides.  
Such a telescoping strategy is a very effective tactic for 
truncating a multi-step synthesis, particularly when conducted in 
a continuous flow manner.[15]  It eliminates the need for 
purification and isolation and allows for the dramatic changes in 
reaction conditions from one step to the next.[16]  Typically, 
deprotection of perbenzoylated ribonucleosides is achieved with 
methanolic ammonia, however, these conditions usually require 
long reaction times that are generally unsuitable for continuous 
flow synthesis.[3a,b]  Nevertheless, taking advantage of the 
“extreme” reaction conditions that can be employed in 
microreactors, we first attempted the single-step ammoniolysis 
of 3i using methanolic NH3 (75 equiv, 7 N) at 200 °C for 10 
min.[17]  However, even under these forcing conditions, the 
deprotection of 3i was incomplete, providing adenosine (5i) and 
5'-O-benzoyladenosine in 53 and 33% yields, respectively. 
A transesterification approach to benzoyl deprotection using 
ethanolic sodium ethoxide solved this problem.  Toward this 
end, the reactor configuration depicted in Scheme 2 was 
assembled, and after minimal optimization, the continuous and 
uninterrupted two-step process (glycosylation; deprotection) 
afforded adenosine (5i) in 98% overall yield (Reactor A: 150 °C, 
5 min; Reactor B: 75 °C, 12 min). 
Unfortunately, these reaction conditions proved unfeasible 
for the synthesis of 5b due to extensive precipitation of the 
product in the proximal part of reactor B.  Recognizing that the 
debenzoylation of the ribofuranose was most likely very fast at 
75 °C (and that product 5b has limited solubility in ethanol), we 
anticipated that slowing down the rate of the deprotection might 
improve the solubility profile of 5b.  By lowering the reaction 
temperature to 40 °C and increasing the residence time to 20 
min, solid formation was minimized and 5b was obtained in 81% 
yield  (Reactor A:  120 °C, 8.3 min; Reactor B: 40 °C, 20 
min).[18]  Utilizing methanolic NaOMe (0.15 M) completely 
eliminated precipitation of the product in reactor B allowing 
nucloeosides 5b and 5e to be successfully obtained in 94 and 
93% respectively (Reactor A:  120 °C, 3 min; Reactor B: 50 °C, 
8 min). Using these conditions, adenosine was also obtained in 
95% yield indicating that this continuous one-flow multi-step 
sequence will be of general use for the synthesis of nucleosides. 
 
Scheme 2. One flow, multi step synthesis of nucleosides 5. 
In summary, the first general method of Brønsted acid-
catalyzed nucleoside synthesis described herein was made 
possible by and is practical because of the flow reaction format.  
The glycosylation catalysts of choice in this rapid, high-yielding, 
continuous, one-flow, multi-step synthesis of nucleosides are 
pyridinium triflates, e.g., 2,6-di-tert-butyl-4-methylpyridinium 
triflate.  This process was scaled easily and without further 
optimization using a commercial flow synthesis instrument.  By 
telescoping the glycosylation and deprotection steps into a 
single, continuous and uninterrupted reactor network, thereby 
circumventing the need to isolate and purify the intermediate 
product, the synthesis of nucleosides has been significantly 
streamlined. 
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